Monitoring the behaviour of 4-ketocyclophosphamide versus cyclophosphamide during capillary gas chromatography by mass spectrometry. 1987

E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
Leiden University Medical Centre, Department of Clinical Oncology, Sylvius Laboratories, The Netherlands.

Capillary Gas Chromatography (CGC) is capable of determining underivatized cyclophosphamide (CPA) using SCOT OV 275 columns. Then CPA is subjected to in situ degradation resulting in formation of a cyclization product which can be determined selectively in biological fluids. In routine bioanalysis however cyclization products of CPA metabolites might interfere, e.g. 4-keto CPA. In the present study possible formation of cyclization products of 4-keto CPA similar to CPA was monitored by Mass Spectrometry. Cyclization of 4-keto CPA in situ was demonstrated to occur, resulting in a product similar to that of CPA. Both cyclization products could be determined selectively and it appeared that in situ cyclization of 4-keto CPA was negligible (less than 5%), probably owing to extra stabilization of the CPA metabolite by keto-enol tautomerism as has been demonstrated by NMR.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
June 1984, Biomedical mass spectrometry,
E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
March 1987, Journal of chromatography,
E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
July 1993, Journal of chromatography,
E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
January 2011, Methods in molecular biology (Clifton, N.J.),
E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
January 1997, International archives of occupational and environmental health,
E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
January 1988, Journal - Forensic Science Society,
E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
October 1988, Biomedical & environmental mass spectrometry,
E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
March 1984, Biomedical mass spectrometry,
E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
July 1997, Analytical chemistry,
E A de Bruijn, and A T van Oosterom, and P A Leclercq, and J W de Haan, and L J van de Ven, and U R Tjaden
September 1991, Analytical chemistry,
Copied contents to your clipboard!